1,726,390 research outputs found
Cancer Research UK Cancer Awareness Measures, 2014
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).
The Cancer Awareness Measure (CAM) is a survey designed to assess public awareness of cancer warning signs/symptoms, cancer risk factors and barriers to help seeking. Data have been collected every two years from 2008 from a representative face to face sample of the population of Great Britain via the Office of National Statistics (ONS) Opinions and Lifestyle Survey. The 2014 survey was conducted online using a GB representative sample (3,044 adults) from Trinity McQueen.
Patients with cancer in the UK tend to present with more advanced disease and have poorer survival rates than their European counterparts. One of the work streams set out in the National Awareness and Early Diagnosis Initiative (NAEDI), which was established under the Department of Health's Cancer Reform Strategy for improving cancer outcomes, has focused on developing a validated standardised measure for the general population, comprising a set of questions designed to reliably assess cancer awareness.
The purpose of the Cancer Awareness Measure (CAM) is to facilitate accurate and sensitive surveillance of public awareness of cancer over time, identify information needs, and monitor the impact of campaigns promoting cancer awareness and early presentation. It helps to develop an in-depth understanding of current awareness, attitudes, beliefs and behaviours in relation to cancer.
Further information about the CAM may be found on the Cancer Research UK Cancer Awareness Measures (CAMs) webpage.
Main Topics:Public awareness of cancerCancer risk factorsBarriers to help seeking</p
Cancer Research UK Cancer Awareness Measures, 2021
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).CAM data has been collected by CRUK approximately every two years from 2008 to 2019, moving to bi-annual in 2021. A COVID specific CAM was developed in 2020 and 2021 to measure the longitudinal impact of COVID-19 pandemic on cancer attitudes and behaviour and understand the contextual influences on cancer attitudes and behaviour during COVID-19.Further information about the CAM may be found on the Cancer Research UK Cancer Awareness Measures (CAMs) webpage.Main Topics:
This CAM questionnaire addressed the following topics:
public awareness of cancer symptoms public knowledge of cancer risk factorsbarriers and enablers to help
seekinguptake of screening programmesbarriers to cancer screening - cervical, breast and bowelexperience of breast and cervical cancer screeningsymptom experienceimpact of COVID-19 on help seeking behaviourco-morbidities perception of symptom seriousnessperceptions of safety from COVID-19 in different medical settingshelp seeking behaviours including remote consultation and re-presentationperceptions of remote consultation demographic variables including health behaviours such as smoking and fruit and vegetable consumption </div
Cancer Research UK Cancer Awareness Measures, September 2023
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).CAM data have been collected by CRUK approximately every two years from 2008 to 2019, moving to bi-annual in 2021. The COVID-specific CAM was developed in 2020 and 2021 to measure the longitudinal impact of the COVID-19 pandemic on cancer attitudes and behaviour and to understand the contextual influences on cancer attitudes and behaviour during the COVID-19 pandemic.Further information about the CAM may be found on the Cancer Research UK Cancer Awareness Measures (CAMs) webpage.For the second edition (February 2025), the data file has been updated with two new ethnicity variables.Main Topics:The CAM questionnaire addressed the following topics:
public awareness of cancer symptomspublic knowledge of cancer risk factorsreasons for patient delay before contacting doctor public knowledge of common cancer types in men and womenpublic awareness of cancer screening programmesdemographic variables</ul
Cancer Research UK Cancer Awareness Measures, February 2022
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).
CAM data have been collected by CRUK approximately every two years from 2008 to 2019, moving to bi-annual in 2021. The COVID specific CAM was developed in 2020 and 2021 to measure the longitudinal impact of COVID-19 pandemic on cancer attitudes and behaviour and to understand the contextual influences on cancer attitudes and behaviour during the COVID-19 pandemic.Further information about the CAM may be found on the Cancer Research UK Cancer Awareness Measures (CAMs) webpage.
Main Topics: This CAM questionnaire addressed the following topics:  uptake of screening programmes - cervical, bowel, breastbarriers to cancer screening - cervical, breast and bowel experience of breast and cervical cancer screening symptom experience perception of symptom seriousness re-presentation and re-contacting GP demographic variables   

Cancer Research UK Cancer Awareness Measures, September 2022
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM). CAM data have been collected by CRUK approximately every two years from 2008 to 2019, moving to bi-annual in 2021. The COVID specific CAM was developed in 2020 and 2021 to measure the longitudinal impact of COVID-19 pandemic on cancer attitudes and behaviour and to understand the contextual influences on cancer attitudes and behaviour during the COVID-19 pandemic.Further information about the CAM may be found on the Cancer Research UK Cancer Awareness Measures (CAMs) webpage. Main Topics:The CAM questionnaire addressed the following topics:public awareness of cancer symptomspublic knowledge of cancer risk factorsbarriers and enablers to help seekinguptake of screening programmes (cervical, bowel, breast)barriers to cancer screening (cervical, breast and bowel)experience of breast and cervical cancer screeningsymptom experience including further testsimpact of COVID-19 on help seeking behaviourco-morbiditiesperception of symptom seriousnesshelp seeking behaviours including remote consultation and re-presentationperceptions of remote consultation</ul
Cancer Research UK Cancer Awareness Measures, 2019
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).
The Cancer Awareness Measure (CAM) is a survey designed to assess public awareness of cancer warning signs/symptoms, cancer risk factors and barriers to help seeking. Data have been collected every two years from 2008 to 2019 from a representative face to face sample of the population of Great Britain via the Office of National Statistics (ONS) Opinions and Lifestyle Survey. The 2019 survey was conducted online using a GB representative sample (3,044 adults) from Trinity McQueen.
Patients with cancer in the UK tend to present with more advanced disease and have poorer survival rates than their European counterparts. One of the work streams set out in the National Awareness and Early Diagnosis Initiative (NAEDI), which was established under the Department of Health's Cancer Reform Strategy for improving cancer outcomes, has focused on developing a validated standardised measure for the general population, comprising a set of questions designed to reliably assess cancer awareness.
The purpose of the Cancer Awareness Measure (CAM) is to facilitate accurate and sensitive surveillance of public awareness of cancer over time, identify information needs, and monitor the impact of campaigns promoting cancer awareness and early presentation. It helps to develop an in-depth understanding of current awareness, attitudes, beliefs and behaviours in relation to cancer.
Further information about the CAM may be found on the Cancer Research UK Cancer Awareness Measures (CAMs) webpage.Main Topics:The CAM questionnaire addressed the following topics:
public awareness of cancer symptomspublic knowledge of cancer risk factorsreasons for patient delay before contacting doctorpublic knowledge of common cancer types in men and womenpublic awareness of cancer screening programmesdemographic variables</ul
Cancer Research UK Cancer Awareness Measures, 2017
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).The CAM has been included in the Opinions and Lifestyle Survey (OLS) which is an omnibus survey ran by the Office for National Statistics (ONS). Data has traditionally been collected via face-to-face in-home interviews. In 2017 a parallel run of data collection was undertaken to explore whether it would be possible to move data collection online. The results of this work revealed that samples collected via online and face to face methods were largely similar, with slight differences in participant characteristics, awareness of cancer signs and symptoms and barriers to help seeking. Based on this work, CAM data will be collected online from 2019.Further information about the CAM, including findings and guidance on the use of CAM, may be found on the Cancer Research UK Cancer Awareness Measures (CAMs) webpage.Main Topics:The Cancer Awareness Measure is a questionnaire designed to assess awareness of cancer among the general population.
The measure includes awareness of warning signs and symptoms, risk factors, attitudes towards help-seeking, awareness of the link between cancer and age, and awareness of the NHS bowel screening programme.
The CAM can be used at national levels in Great Britain to monitor awareness over time, compare awareness and attitudes between groups, identify information needs, and monitor the impact of awareness-raising interventions.</p
Cancer Research UK Cancer Awareness Measures, February 2023
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).
CAM data has been collected by CRUK approximately every two years from 2008 to 2019, moving to bi-annual in 2021. A COVID-specific CAM was developed in 2020 and 2021 to measure the longitudinal impact of COVID-19 on cancer attitudes and behaviour and understand the contextual influences on cancer attitudes and behaviour during COVID-19.
Further information about CAM may be found on the CRUK Cancer Awareness Measure (CAM) webpage. CRUK will validate the latest survey in partnership with the Centre for Health Service Studies at the University of Kent.
Main Topics:The CAM questionnaire addressed the following topics:public awareness of cancer symptomspublic knowledge of cancer risk factorsreasons for patient delay before contacting doctorpublic knowledge of common cancer types in men and womenpublic awareness of cancer screening programmesdemographic variables</ul
Cancer Research UK Local Cancer Awareness Measure: Leicester, Leicestershire and Rutland (LLR), April-August 2024
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).In 2023-2024 Cancer Research UK ran two Local Cancer Awareness Measure Plus (CAM+) pilots, collecting data in two local regions (Greater Manchester and Leicester, Leicestershire and Rutland (LLR)) using both an online panel and community sampling to recruit participants. The Greater Manchester pilot Local CAM+ datasets are available under SNs 9342 and 9358.The LLR pilot Local CAM+ dataset does not include National CAM+ questions on alcohol consumption, physical activity, perception of health services capacity and closeness to cancer. However, it includes additional questions on possible facilitators for cancer screening attendance and willingness to travel for hospital tests.A Special Licence version of this data, including more geography and demographic variables, is available under SN 9359.Further information about the CAM+ may be found on the Cancer Research UK Cancer Awareness Measure Plus (CAM+) webpage.Main Topics:The CAM questionnaire addressed the following topics:public awareness of cancer symptomspublic knowledge of cancer risk factorsbarriers and enablers to help seekinguptake of screening programmesbarriers to cancer screening (cervical, breast and bowel)experience of breast and cervical cancer screeningsymptom experienceco-morbiditiesperception of symptom seriousnesshelp seeking behaviours including remote consultation and re-presentationperceptions of remote consultationdemographic variables including health behaviours such as smoking.</div
Cancer Research UK Local Cancer Awareness Measure: Greater Manchester, April-May 2024
No full textAbstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).In 2023-2024 Cancer Research UK ran two Local Cancer Awareness Measure Plus (CAM+) pilots, collecting data in two local regions (Greater Manchester and Leicester, Leicestershire and Rutland (LLR)) using both an online panel and community sampling to recruit participants. The LLR pilot Local CAM+ datasets are available under SNs 9343 and 9359.The Greater Manchester (GM) pilot Local CAM+ dataset does not include National CAM+ questions on alcohol consumption, physical activity, perception of health services capacity and closeness to cancer. However, it includes additional questions on possible facilitators for cancer screening attendance and willingness to travel for hospital tests.A Special Licence version of this data, including more geography and demographic variables, is available under SN 9358.Further information about the CAM+ may be found on the Cancer Research UK Cancer Awareness Measure Plus (CAM+) webpage.
Main Topics:The CAM questionnaire addressed the following topics:
public awareness of cancer symptomspublic knowledge of cancer risk factorsbarriers and enablers to help seekinguptake of screening programmesbarriers to cancer screening (cervical, breast and bowel)experience of breast and cervical cancer screeningsymptom experienceco-morbiditiesperception of symptom seriousnesshelp seeking behaviours including remote consultation and re-presentationperceptions of remote consultationdemographic variables including health behaviours such as smoking.</ul
- …
